// App-Quantinova.ai

BSH2020‐PO‐025 : CDx report program – assessment of the current reporting practice for haemato‐oncology companion diagnostics (CDx) markers in the UK and Ireland

Researchers

Presenter

  • P. Evans

Principal Investigators

  • D. Wilkinson

  • J. Mason

  • S. Delic

  • N. Atkey

Medical Centers

  • St James's Institute of Oncology, St James's University Hospital, Leeds, UK

  • Global Lab Team, Diaceutics, Belfast

  • West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust Mindelsohn Way, Birmingham, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Abelson murine leukemia viral oncogene homolog

  • Alpha-tubulin N-acetyltransferase 1

  • Breakpoint Cluster Region

  • Fms related tyrosine kinase 3

  • Immunoglobulin heavy-chain variable region gene

  • Isocitrate dehydrogenase 1

  • Isocitrate dehydrogenase 2

  • Tumor protein p53

Drug/Treatment

  • Methadone hydrochloride

  • TP53

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved